These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 21904150

  • 1. Treatment of diverticular disease of the colon and prevention of acute diverticulitis: a systematic review.
    Maconi G, Barbara G, Bosetti C, Cuomo R, Annibale B.
    Dis Colon Rectum; 2011 Oct; 54(10):1326-38. PubMed ID: 21904150
    [Abstract] [Full Text] [Related]

  • 2. [Role of rifaximin in the treatment of colonic diverticular disease].
    Moretti A, Spagnolo A, Mangone M, Chiesara F, Aratari A, Papi C, Koch M.
    Clin Ter; 2012 Oct; 163(1):33-8. PubMed ID: 22362232
    [Abstract] [Full Text] [Related]

  • 3. Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon.
    Tursi A, Papa A, Danese S.
    Aliment Pharmacol Ther; 2015 Sep; 42(6):664-84. PubMed ID: 26202723
    [Abstract] [Full Text] [Related]

  • 4. Mesalazine for People with Diverticular Disease: A Systematic Review of Randomized Controlled Trials.
    Iannone A, Ruospo M, Wong G, Barone M, Principi M, Di Leo A, Strippoli GFM.
    Can J Gastroenterol Hepatol; 2018 Sep; 2018():5437135. PubMed ID: 30320044
    [Abstract] [Full Text] [Related]

  • 5. Mesalazine to treat symptomatic uncomplicated diverticular disease and to prevent acute diverticulitis occurrence. A systematic review with meta-analysis of randomized, placebo-controlled trials.
    Picchio M, Elisei W, Tursi A.
    J Gastrointestin Liver Dis; 2018 Sep; 27(3):291-297. PubMed ID: 30240473
    [Abstract] [Full Text] [Related]

  • 6. Mesalamine (5-ASA) for the prevention of recurrent diverticulitis.
    Carter F, Alsayb M, Marshall JK, Yuan Y.
    Cochrane Database Syst Rev; 2017 Oct 03; 10(10):CD009839. PubMed ID: 28973845
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mesalazine for the Treatment of Symptomatic Uncomplicated Diverticular Disease of the Colon and for Primary Prevention of Diverticulitis: A Systematic Review of Randomized Clinical Trials.
    Picchio M, Elisei W, Brandimarte G, Di Mario F, Malfertheiner P, Scarpignato C, Tursi A.
    J Clin Gastroenterol; 2016 Oct 03; 50 Suppl 1():S64-9. PubMed ID: 27622370
    [Abstract] [Full Text] [Related]

  • 10. Management of diverticular disease: is there room for rifaximin?
    Papi C, Koch M, Capurso L.
    Chemotherapy; 2005 Oct 03; 51 Suppl 1():110-4. PubMed ID: 15855755
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Colonic diverticular disease. Treatment and prevention.
    Gargallo Puyuelo CJ, Sopeña F, Lanas Arbeloa A.
    Gastroenterol Hepatol; 2015 Dec 03; 38(10):590-9. PubMed ID: 25979437
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Rifaximin in the management of colonic diverticular disease.
    Latella G, Scarpignato C.
    Expert Rev Gastroenterol Hepatol; 2009 Dec 03; 3(6):585-98. PubMed ID: 19929580
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Colonic diverticular disease.
    Simpson J, Spiller R.
    Clin Evid; 2004 Dec 03; (12):599-609. PubMed ID: 15865664
    [No Abstract] [Full Text] [Related]

  • 20. Review article: uncomplicated diverticular disease of the colon.
    Petruzziello L, Iacopini F, Bulajic M, Shah S, Costamagna G.
    Aliment Pharmacol Ther; 2006 May 15; 23(10):1379-91. PubMed ID: 16669953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.